| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.7M | +110.6% |
| Cost of Revenue | $11.7M | +106.8% |
| Gross Profit | $2.0M | +135.6% |
| R&D Expense | $270K | +1385.5% |
| SG&A Expense | $3.5M | +86.3% |
| Operating Income | -$5.4M | -37.4% |
| Interest Expense | $781K | -9.6% |
| Pre-tax Income | -$6.1M | -28.9% |
| Net Income | -$6.1M | -28.9% |
| EPS (Basic) | -$0.57 | +31.3% |
| EPS (Diluted) | -$0.57 | +31.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Accounts Receivable | $1.3M | +215.2% |
| Inventory | $2.4M | +23.5% |
| Current Assets | $5.7M | +15.6% |
| Total Assets | $14.5M | +12.5% |
| Current Liabilities | $6.3M | -28.9% |
| Long-term Debt | $4.9M | — |
| Total Liabilities | $8.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | -44.0% |
| Capital Expenditures | $747K | -73.8% |
| Investing Cash Flow | -$747K | +73.5% |
| Financing Cash Flow | $6.0M | -35.9% |
| Free Cash Flow | -$7.7M | -0.5% |
| -15.5% |
| Stockholders' Equity | $5.6M | +137.9% |